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ABSTRACT: Out of their niche environment, adult stem
cells, such as mesenchymal stem cells (MSCs), sponta-
neously diﬀerentiate. This makes both studying these
important regenerative cells and growing large numbers
of stem cells for clinical use challenging. Traditional cell
culture techniques have fallen short of meeting this
challenge, but materials science oﬀers hope. In this study,
we have used emerging rules of managing adhesion/
cytoskeletal balance to prolong MSC cultures by fabricating
controllable nanoscale cell interfaces using immobilized
peptides that may be enzymatically activated to change their
function. The surfaces can be altered (activated) at will to tip adhesion/cytoskeletal balance and initiate diﬀerentiation,
hence better informing biological mechanisms of stem cell growth. Tools that are able to investigate the stem cell
phenotype are important. While large phenotypical diﬀerences, such as the diﬀerence between an adipocyte and an
osteoblast, are now better understood, the far more subtle diﬀerences between ﬁbroblasts and MSCs are much harder to
dissect. The development of technologies able to dynamically navigate small diﬀerences in adhesion are critical in the race
to provide regenerative strategies using stem cells.
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I n vivo, adult stem cells reside within a specializedenvironment known as the niche. The niche is made upof cellular and noncellular components, including resident
stem cells, support cells, and extracellular matrix (ECM) that,
together, regulate stem cell self-renewal.1−4
Traditional culture plastics present a diﬀerent environment
to the in vivo niche, and hence mesenchymal stem cells (MSCs)
spontaneously diﬀerentiate to a heterogeneous population
mainly made up of ﬁbroblasts.5 Thus, understanding and
ultimately controlling MSC growth is desirable.
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In vitro materials-based strategies have been critical for
understanding how cells adhere, for example, in showing that
MSCs require a minimum patterned area of 69 μm2 of
ﬁbronectin per 1000 μm2 of surface in order for adhesions to
form6 and that integrin composition and spacing are critical in
integrin gathering and adhesion maturation.7,8 As biomaterials
Figure 1. Dynamic, enzyme cleavable surfaces for MSC growth. (A) Cartoon representation of the FMOC and PEG blocked RGD surfaces
illustrating the elastase cleavage site. Plain glass coverslips were modiﬁed using silanization and PEGylation steps followed by solid-phase
peptide synthesis to build up the full structure in a stepwise manner. The incorporation of a dialanine enzyme cleavable linker facilitates the
removal of the FMOC/PEG blocking group, thereby forming the basis of the switch. (B) ToF-SIMS image shows a uniform chemical surface
composition on the micron scale and conﬁrms that PEG, FMOC, and amino acids (shown as the sum of the indicated representative peaks for
each amino acid) are only detected in the analysis where expected; that is, FMOC only seen on the FMOC-D surface and amino acids was
only noted when the AARGD sequence was present. Color scales represent ion counts. Images for speciﬁc ions are presented on the same
scale for all samples; total ion images are scaled to their individual range. Note that inset images in the FMOC column are all similarly
brightness-enhanced versions of the main images to show diﬀerences more clearly. (C) MSCs were cultured on plain glass coverslips for 48 h
and treated with diﬀerent concentrations of elastase ranging from 1.0 to 0.1 mg/mL (4.60 to 0.460 U) in basal cell culture medium. Live/dead
stain for elastase tolerance showed that while cell adhesion was clearly aﬀected at the higher concentrations, few remaining dead cells were
noted with any elastase concentration (they may have detached). However, cells incubated with 0.1 mg/mL elastase were indistinguishable
from controls, whereas the positive controls (ethanol addition) indicated uptake of the ethidium homodimer; thus these cells were dead. (D)
Surface-bound FMOC groups were seen to ﬂuoresce at a wavelength of 315 nm (left-hand spectrum), and piperidine cleavage resulted in a
loss of this signal (middle spectrum). At 0.1 mg/mL, it was seen that elastase cleaved surface-bound FMOC (right-hand spectrum); n = 3.
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can be used to control focal adhesion formation, they can thus
be used to tune MSC phenotype.9,10 It has been shown that if
MSCs are allowed to spread, form large adhesions, and develop
a highly contractile cytoskeleton, they diﬀerentiate into
osteoblasts.11−16 If, however, the MSCs are prevented from
spreading, low intracellular tension and resultant adipogenesis
follows.11−16 These rules have been devised using techniques
such as microcontact printing of adhesive patterns,11,17,18
control of stiﬀness/cross-linking density,12,13,19 changing
grafted chemistries,20,21 employing stress relaxation,22,23 and
using deﬁned nanotopographies.24
Of these, only nanotopography has been shown to also be
able to facilitate prolonged MSC growth with retained
multipotency.5 Enhanced MSC self-renewal required a slightly
lower level of adhesion and cytoskeletal tension than on
controls where spontaneous and untargeted diﬀerentiation to
ﬁbroblasts was observed.25 As MSCs have ﬁbroblastic
morphology,26 the morphology/adhesion/tension diﬀerence
between a ﬁbroblast and a MSC is small. Thus, as it is
challenging to control cell tension so subtly, the rules for in
vitro prolonged MSC growth with multipotency retained
remain unclear, and platforms able to achieve this are a scarce
resource for the study of how stem cells work.
An optimal cell/material interface would allow dynamic
regulation of intracellular tension so that it would be possible to
prove that altering the growth adhesion state results in
diﬀerentiation. While examples of in situ change of surface
properties exist, these switches involve uncaging and switching
between inactive (no adhesion, cell quiescence) and active
states (diﬀerentiation) and thus are not suited to a more subtle
regulation of adhesion required to probe stem cell growth.
Dynamic culture systems are emerging largely based on light-
sensitive27−29 surfaces. Typically, a caging group is removed to
reveal the cell adhesive tripeptide RGD (arginine, glycine,
aspartic acid), which binds integrins and hence regulates
adhesion and intracellular tension.27,28,30
The ﬁrst MSC dynamic system involved MSCs adhering to
pendular RGD incorporated within a polyethylene glycol
(PEG)-based hydrogel.31 Photocleavage was used to release
the RGDs from the hydrogel, resulting in chondrogenesis as the
MSCs rounded up.31 While clearly demonstrating that it is
possible to control cell fate using changes in cell adhesion, this
study had limitations as cell viability and expansion were limited
in the hydrogels. Another study illustrated the potential for
targeting osteogenesis from MSCs in 3D gels over short culture
times, but control over cell growth was not achieved.32
Electroactive surfaces33−35 and protein-responsive materi-
als36 are also of interest in this area. However, these studies rely
on nonbiological chemistries and use of conducting materials/
electrochemical potentials that may aﬀect cell response, and
none demonstrated the ability to support prolonged multi-
potency or the ability to modulate the environment to allow
observation of changes that occur as diﬀerentiation is initiated.
Recently, mechano-activated surfaces have gained interest
based on concepts of opening of cryptic sites in proteins.37,38
We, however, chose to employ enzymatic activation to
provide a natural stimulus to trigger changes in material
properties, with advantages of biocompatibility and selectivity.39
Here, we present a dynamic surface where both the caging
group and the hidden group have discrete and tunable
biological roles and show that adhesion can be subtly tuned
to turn MSCs from a growth state with multipotency retained
to a diﬀerentiating state that allows us to elucidate in vitro MSC
growth mechanisms.
RESULTS AND DISCUSSION
Synthesis of a User-Controlled Nanointerface. Surfaces
were synthesized by silanizing glass coverslips and covalently
attaching a PEG monolayer onto which ﬂuorenylmethylox-
ycarbonyl (FMOC)-amino acids were iteratively coupled using
solid-phase peptide synthesis directly on the PEGylated glass
surface. The complete surface consists of the integrin binding
RGD peptide or integrin inactive RGE peptide, followed by an
elastase cleavable dialanine (AA) linker and then either FMOC
as a steric blocking group, or PEG as an adhesion-reducing
blocking group. Hence, the ﬁnal full sequences were either
FMOC-AARGD/E or PEG-AARGD/E, where D/E refers to
RGD or RGE constructs. The FMOC protecting moiety
sterically prevents cells from fully interacting with the
underlying RGD ligands.40 Elastase removes the FMOC/PEG
blocking group exposing RGD, that is, FMOC-A↓ARGD or
PEG-A↓ARGD, where ↓ refers to the cleavage point (Figure 1A
and Supplementary Figure 1). Using optimized protocols,41
synthesis was followed using a combination of solid-state
ﬂuorescence spectroscopy (SSFS), water contact angle
measurements, and time-of-ﬂight secondary ion mass spec-
trometry (Figure 1B and Supplementary Figures 2 and 3).
In order to activate the surface in situ, elastase concentration
was optimized so the blocking group could be cleaved from the
surface without aﬀecting cell adhesion/viability. MSC adhe-
sion/viability was assessed by incubating the cells with diﬀerent
elastase concentrations (1.0−0.1 mg/mL, 4.60−0.460 U) and
using a live/dead stain. Between 1.0 and 0.4 mg/mL, MSCs
were rounded up and detached, while at 0.2 mg/mL, some live
cells remained attached though poorly spread. At 0.1 mg/mL,
cell adhesion/viability was indistinguishable from controls
(Figure 1C) and no detrimental aﬀects were identiﬁed
(Supplementary Figure 4). SSFS conﬁrmed that 0.1 mg/mL
elastase could cleave AA and remove FMOC (Figure 1D). ToF-
SIMS was employed to indicate that, after FMOC cleavage,
RGD was still in place (Supplementary Figure 5). Note that
cleavage can be controlled as changing AARGD to phenyl-
alanine (F)ARGD creates a shift from 29 to 50% FMOC
cleavage, respectively (Supplementary Figure 6), and this
should allow control of how adhesive the surface is or even
permit sequential RGD% exposure to the cells.
For FMOC blocking groups, uncleaved substrates are
referred to as FMOC-RGD and FMOC-RGE, respectively,
and cleaved substrates are referred to as RGD and RGE. Plain
glass, PEG18, RGD, and RGE controls were also used, and PEG
blocked substrates used in later experiments.
Dynamic Targeting of MSC Adhesions. MSCs were
seeded on plain, PEG18, RGD/E controls, FMOC-RGD/E, and
surfaces pretreated with 0.1 mg/mL elastase to remove the
FMOC blocking group (RGD/E). As expected, poor cell
adhesion was observed on PEG18, RGE controls, FMOC-RGD/
E, and cleaved RGE substrates. In comparison, cells seeded on
plain, RGD controls, and cleaved RGD surfaces adhered well;
this is in line with hypothesized adhesion results (i.e., high
adhesion on plain glass and surfaces with RGD exposed).
Viability assay conﬁrmed that all surfaces supported cell growth
(Supplementary Figures 7 and 8).
Seeding density was also optimized and 75, 39, and 7 cells/
mm2 tested. All samples were cultured for 7 days with half of
the FMOC-RGD/E substrates cultured as uncleaved (or
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adhesion “low”) for 48 h before switching to cleaved (or
adhesion “high”) using elastase (2 days “low” and 5 days
“high”). High cell density (75 cells/mm2) muted the eﬀects of
spreading from the “low” to “high” state, while lower cell
densities (39 and 7 cells/mm2) exhibited markedly diﬀerent
degrees of cell spreading between these substrates (Supple-
mentary Figures 8−10). This is in agreement with previous
reports illustrating that reduction in cell−cell signaling is
important to amplify cell−material signaling.12 An amount of 7
cells/mm2 was selected as optimal because, postcleavage, the
MSCs acted as if on RGD control.
Adhesion and resultant intracellular tension were further
studied through vinculin (present in cell adhesions) and p-
myosin (pSer 19 was chosen as it phosphorylates Rho-
associated protein kinase involved in cytoskeletal
contraction11) immunoﬂuorescence. After 7 days of culture
(2 days “low” and 5 days “high” for cleaved substrates),
adhesions were classiﬁed by length42 as focal complexes (FX,
<1 μm), focal adhesions (FA, 1−5 μm), and supermature
adhesions (SMAdh, >5 μm). Imaging of vinculin and actin
cytoskeleton demonstrated poor adhesion and few stress ﬁbers
in cells cultured on PEG18, RGE controls, FMOC-RGE, cleaved
RGE, and FMOC-RGD (low) substrates. In contrast, increased
adhesion numbers and numerous stress ﬁbers were seen in cells
on plain, RGD controls, and cleaved RGD (high) samples
(Figure 2A).
All observations thus ﬁt with the hypothesis that FMOC-
RGD permitted only cells with a similar adhesion proﬁle to
RGE, but as the surfaces were switched from the “low” to the
“high” mode, larger cell adhesions became established, similar
to RGD controls (Figure 2B and Supplementary Figure 11).
When p-myosin expression was considered, the cells were
observed to switch from a lower tension phenotype to a higher
one when FMOC-RGD surfaces were enzymatically switched
from “low” to “high”. MSCs cultured on FMOC-RGD surfaces
exhibited p-myosin levels only slightly higher than those of cells
cultured on RGE containing substrates, whereas p-myosin
expression for MSCs seeded on cleaved RGD surfaces was
similar to levels expressed by cells cultured on the RGD control
(Figure 2B). Critically, in line with nanotopographical studies,
the number of SMAdhs and p-myosin expression was
signiﬁcantly lower on FMOC-RGD substrates than on glass
Figure 2. Dynamic control of MSC adhesion and tension. (A) MSCs cultured at 7 cells/mm2 were seen to spread to a greater degree on plain
controls, RGD controls, FMOC-RGD (low), and cleaved RGD (high) surfaces and to a smaller degree on PEG18 and all RGE surfaces,
creating a pronounced cell size diﬀerence between the surfaces. As morphology was altered, adhesion and cytoskeletal arrangement also
changed with RGD controls and cleaved RGD (high) surfaces, supporting more organized stress ﬁbers and larger adhesions. Red = actin,
green = vinculin, and blue = nuclei. (B) Adhesion subtypes were recorded as a percentage of the average number of adhesions identiﬁed per
cell. The majority of adhesions were focal adhesions (FAs), with focal complexes (FXs) and supermature adhesions (SMAdhs) making up a
much smaller percentage. As a whole, more FXs were observed per cell on plain, PEG18, RGE controls, FMOC-RGD (low), and cleaved RGE
substrates, while more SMAdhs were observed on RGD controls and cleaved RGD (high) surfaces. In line with diﬀerences in cell size and
adhesion length, p-myosin expression, as a measure of cytoskeletal tension, showed the cells were under increased tension on RGD controls
and cleaved RGD (high) surfaces. Error bars are standard error of the mean; stars indicate signiﬁcant diﬀerence between groups as
determined by one-way ANOVA and Dunn’s post-hoc test, where *P < 0.5, **P < 0.01, and ***P < 0.001 - § = plain/PEG diﬀerent to RGD by
P < 0.05; n = 40 cells per substrate and three material replicates.
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controls, supporting that MSC growth requires a lower
tensional state than ﬁbroblastic growth.5,25
To ascertain if FMOC-RGD substrates do support MSC
growth, cell proliferation was assessed on plain, FMOC-RGD,
FMOC-RGE, and RGD and RGE controls by analyzing
bromodeoxyuridine (BrdU) uptake. Similar numbers of
BrdU-positive cells were observed at day 1 of culture, but by
day 4, active proliferation was only signiﬁcantly increased on
FMOC-RGD (low) (Supplementary Figure 12A). Further-
more, cell counts over 28 days showed cell expansion was
greatest on uncleaved FMOC-RGD (low), in line with MSCs
being faster growing than diﬀerentiated cells (Supplementary
Figure 12B). Moving into functional analysis, we discounted all
RGE and PEG18 substrates because cell numbers were
considered too low to gather meaningful data.
To understand the ﬁrst stages of diﬀerentiation related to
adhesion, we examined roles for integrins β1 (part of the
ﬁbronectin (FN) receptor) and β5 (can form part of the
vitronectin (VN) receptor and has been identiﬁed previously as
being important in MSC osteogenic commitment43), the bone
morphogenetic protein 2 (BMP2) receptor BMPR1a, and ezrin
(anchors stress ﬁbers to the cell membrane). After 48 h of
culture, elastase was added to half the cultures to reveal RGD
(t0) and then receptor colocalization followed for 48 h. For
MSCs on FMOC-RGD (low) substrates, adhesions were
largely punctate and β1-based, suggesting predominantly FN-
receptor-mediated attachments with negligible BMPR1a
colocalization or β5 expression (Figure 3A,B). However, on
cleaved RGD (high) surfaces, MSCs were seen to express
highly colocalized β5 and BMPR1a with elongated adhesion
morphologies (Figure 3B). These data agree with reports
showing that cells bridge adhesions better using VN receptors,
allowing larger adhesions to form.44
For ezrin, MSCs on FMOC-RGD (low) surfaces had close
colocalization of stress ﬁbers and ezrin (Figure 3C). However,
on cleaved RGD (high) surfaces, ezrin relocated, becoming
associated with cortical actin (Figure 3C). We can postulate
that this allows for stress ﬁber remodeling required as the
MSCs adapt to their new environments and increase adhesion.
Indeed, if ezrin is knocked down with siRNA, runt-associated
transcription factor 2 (RUNX2, an osteogenic transcription
regulator) phosphorylation, hence activation, increases (Figure
3C).
Controlling Adhesion Retains MSC Phenotype. Follow-
ing from observations of adhesion changes, we need to consider
if these translate into an ability to control phenotype. Thus,
phenotypical analyses of the MSC growth markers STRO-1 and
activated leukocyte cell adhesion molecule (ALCAM) and the
osteoblast markers osteopontin (OPN) and osteocalcin (OCN)
were next used in longer-term cultures. The cells grew to form
areas of conﬂuence on glass, RGD controls, FMOC-RGD
(low), and cleaved RGD (high) surfaces as could be seen at day
7 (2 days “low” and 5 days “high” for cleaved RGD;
Supplementary Figure 13). While MSCs on all surfaces
retained expression of STRO-1 and ALCAM, it appeared that
MSCs on the RGD controls and cleaved RGD (high) surfaces
had started to express OPN and OCN. Image analysis for OCN
at days 1, 3, and 5, however, showed negligible OCN at days 1
and 3 and a signiﬁcant change in osteogenesis only on RGD
controls (where cells had been exposed to RGD longest) at day
5 (Supplementary Figure 14).
By day 21 (2 days “low” and 19 days “high” for cleaved
RGD), these diﬀerences were clear. On RGD controls and
cleaved RGD surfaces, the cells expressed low levels of STRO-1
and ALCAM and high levels of OPN and OCN (Figure 4A).
Image analysis of STRO-1 expression at days 7, 14, and 21
illustrated a homogeneous STRO-1 starting population at day 7
on all materials, with STRO-1 levels then falling with time
Figure 3. Integrin, BMP2 receptor, and cytoskeletal tethering
changes in MSCs on dynamic surfaces. (A) Integrin β1 and
BMPR1a staining in MSCs cultured on FMOC-RGD (low) at t0 (t0
is after 48 h of culture immediately before addition of elastase) and
then after 24 and 48 h post-elastase treatment (cleaved RGD) or in
FMOC-RGD surfaces. β1 was observed to be found in punctate
adhesions, with little BMPR1a colocalization noted (48 h inset).
On the cleaved RGD (high) surfaces, BMPR1a was seen with
adhesion morphology but in diﬀerent areas to the regions of β1
localization (48 h outset). (B) Integrin β5 and BMPR1a staining in
MSCs on FMOC-RGD surfaces at t0 (immediately before addition
of elastase) and then at 24 and 48 h post-elastase (cleaved RGD) or
in FMOC-RGD surfaces. On the FMOC-RGD surfaces, little β5
expression and no BMPR1a colocalization were observed.
However, on the cleaved surfaces, strong β5/BMPR1a colocaliza-
tion was noted by 24 h (outset images). (C) Actin/ezrin
colocalization could be seen at t0 and on FMOC-RGD. However,
for cleaved RGD samples, ezrin appeared to colocalize with cortical
actin at the cell periphery (arrows). SiRNA knock-down of ezrin
resulted in an increase in pRUNX 2 5 days post-switch. For
pRNUX2, in-cell western analysis, n = 3, results are mean ± SD,
stats by ANOVA and Dunn’s post-hoc test where *P < 0.05.
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(Figure 4B). It is noteworthy that, at day 14, STRO-1 levels
were highest on the cleaved RGD (high) surfaces, possibly
reﬂecting a lag due to the switch. However, by day 21, as
osteogenic markers were expressed on the cleaved surface,
STRO-1 expression was reduced to 15% of cells comparable to
12.2% in cells on the glass control. In contrast, on the FMOC-
RGD (low) surface, 30.5% of MSCs retained STRO-1
expression; MSCs could be removed from this surface after
21 day culture and multipotency demonstrated (Supplementary
Figure 15).
Quantiﬁcation of OPN and OCN at 21 days of culture
indicated that FMOC-RGD (low) and plain controls had low
levels of bone marker expression, wheras signiﬁcantly elevated
levels were observed on the RGD control and cleaved RGD
surface (Figure 4C,D). In addition, we checked for the
expression of chondrogenic (collagen II) and adipogenic
(fatty acid binding protein, FABP) markers. We observed
negligible evidence for signiﬁcant expression of either chondro-
genesis or adipogenesis (Supplementary Figure 16), illustrating
that targeted diﬀerentiation toward a high-tension phenotype,
osteogenesis, was achieved on the RGD-exposed surfaces.
Osteogenesis for MSCs on the RGD control and cleaved RGD
(high) surfaces was conﬁrmed at 28 days (Supplementary
Figure 17).
Adhesion/Phenotype Changes Are Reﬂected in MSC
Metabolic Activity. To support phenotypical data, metab-
olomic analysis was carried out to gain a deeper understanding
of MSC metabolism during in situ activation as it has been
previously shown that the stem cell metabolome becomes
activated upon diﬀerentiation.5,25,45,46 Untargeted mass spec-
trometry analysis of metabolites from MSCs cultured on
FMOC-RGD (low) at 2 and 4 days versus MSCs on plain
controls at similar time points showed only a slight
metabolomic change between both time points (Figure
5A,B). However, when FMOC was then cleaved from the
surface on day 2 to reveal the RGD ligand (high) and cultured
for a further 2 days, changes became highly signiﬁcant; that is,
metabolome activation was observed (Figure 5C). When the
culture time was expanded to 7 days (2 days “low” and 5 days
“high” for cleaved RGD), metabolic diﬀerences increased.
Principle component analysis showed that the FMOC-RGD
(low) metabolome was more homogeneous than for MSCs on
the plain control or cleaved RGD (high) surfaces, where
heterogeneous metabolomic proﬁles were identiﬁed (Figure
5D). It has also been proposed that self-renewing embryonic
stem cell45 and MSC5 populations pool unsaturated metabo-
lites to allow for redox plasticity; this trend is seen in the lipid
metabolites in this current study (Figure 5E).
Ingenuity pathway analysis allowed us to observe that fewer
metabolic pathways were diﬀerentially regulated with less
signiﬁcance in MSCs on the FMOC-RGD (low) surface
compared to that on the cleaved RGD (high) surface (Figure
Figure 4. Analysis of MSC growth and diﬀerentiation at days 7 and
21. (A) Immunoﬂuorescence images of STRO-1 MSCs at day 21. At
this time point, the STRO-1 marker had substantially decreased on
all surfaces, remaining only on plain controls and FMOC-RGD
(low) surfaces (outset images). ALCAM was still easily detectible
on the plain controls and FMOC-RGD but reduced on RGD
controls and cleaved RGD (high) surfaces. OPN and OCN levels
were increased on RGD controls and cleaved RGD with respect to
the other surfaces. Red = actin, green = STRO-1/ALCAM/OPN/
OCN, and blue = nuclei; scale bar is 100 μm. (B) Graphs show
quantiﬁcation of STRO-1 expression at 7, 14, and 21 days of
culture. At day 7, almost all cells on plain controls, FMOC-RGD,
and cleaved RGD surfaces expressed STRO-1. This reduced with
time until, at day 21, less that 15% of cells on plain controls and the
cleaved RGD surface retained STRO-1 expression, while double
this number, >30%, retained STRO-1 expression on FMOC-RGD
(approximately 100 cells were included in the quantiﬁcation; n =
2). (C) OCN quantiﬁcation. Data represent OCN levels expressed
by MSCs cultured on plain glass, RGD controls, FMOC-RGD, and
cleaved RGD surfaces at days 7 and 21 of culture. OCN expression
Figure 4. continued
was observed to increase most on RGD controls and cleaved RGD
compared to the other surfaces. (D) OPN quantiﬁcation. Data
represent OPN levels expressed by MSCs seeded on plain glass,
RGD controls, FMOC-RGD, and cleaved RGD at days 7 and 21 of
culture. OPN expression was observed to increase most on the
RGD controls and cleaved RGD surfaces. Statistics carried out by
one-way ANOVA and Dunn’s post-hoc test, where *P < 0.05, **P <
0.01, and ***P < 0.001, n = 3. Note that au = arbitrary units.
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5F,G). These include pathways involved in energy (energy
production, lipid and carbohydrate metabolism), growth (cell
proliferation and nucleic acid metabolism), protein (post-
translational modiﬁcation and cellular development), and
skeletal development. Furthermore, most highly modulated
networks for MSCs on FMOC-RGD (low) illustrated
metabolic regulation linked to cell growth control. When
similar networks were considered for cells on cleaved RGD
(high), metabolic regulation appeared less signiﬁcant (Supple-
mentary Figures 18 and 19).
Long-Term MSC Growth Control. Next, we wanted to
examine if our “low” maintenance state could work for
prolonged cultured before switching to “high”, thus further
demonstrating that adhesion was responsible for growth/
osteogenesis. Thus, we cultured the MSCs for 2 weeks rather
than 2 days before adding elastase and then allowed the cells to
grow a further 2 weeks before staining for STRO-1. With the
longer time to trigger, loss of STRO-1 on the cleaved RGD
surface (high) was not seen, suggesting retention of multi-
potency rather than diﬀerentiation (Supplementary Figure 20).
Working on the hypothesis that the FMOC group becomes
Figure 5. Metabolite analysis of MSCs on dynamic surfaces. (A−C) Putative metabolites were analyzed using MetaboAnalyst 2.0, and the data
were displayed as volcano plots relative to D2-plain (plain control at day 2). The y-axis refers to the p value (determined by two-tailed t test),
with the x-axis intercept set at P = 0.05 so that all data points above the x-axis represent metabolites that were signiﬁcantly diﬀerent from
controls. The x-axis represents fold change as a measure of the magnitude in diﬀerence between samples and the control. Data points to the
left of the y-axis are metabolites down-regulated with respect to controls, and data points on the right of the y-axis were up-regulated (n = 3).
(D) At 7 days (2 days “low” and 5 days “high” for cleaved RGD), principle component analysis showed very clear metabolomic diﬀerences
with MSCs on the FMOC-RGD (low) surface having a highly homogeneous metabolome, more so than on the controls, and the cleaved RGD
(high) surfaces having a far more heterogeneous metabolome (n = 3). (E) Heatmap of putatively detected unsaturated lipids after 7 days
culture showing up-regulation in MSCs on the FMOC-RGD surface and down-regulation in MSCs on the cleaved RGD surface (n = 3). (F,G)
Ingenuity functional pathway analysis illustrating more signiﬁcantly altered functional pathways in MSCs on the cleaved RGD surface (F)
compared to those on FMOC-RGD surfaces (G). Functions include carbohydrate, small molecule, nucleic acid, lipid and vitamin metabolism,
cell growth and proliferation, and skeletal development pathways (statistics by Fischer’s exact test, P < 0.05 represented by bars higher than
the threshold arrow, n = 3).
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coated in ECM proteins reducing elastase eﬃciency, we
substituted the FMOC blocking group for PEG to reduce
protein adsorption.
As with FMOC-RGD, MSCs were seen to expand on PEG-
RGD and retain STRO-1 expression, which was reduced on
plain controls (Figure 6A,B). However, unlike with FMOC,
switching from PEG-RGD to its corresponding cleaved
counterpart resulted in focal adhesion elongation and reduction
in STRO-1, demonstrating that stimulus-initiated cell diﬀer-
entiation with elastase could be achieved with longer culture
(Figure 6A,B). Metabolomic analysis after 7 days culture (2
days “low” then 5 days “high” for cleaved RGD) again showed
that the inactive RGD surface (PEG-RGD) had the most
homogeneous metabolome, while cleaved RGD surfaces had a
more heterogeneous metabolome indicative of a change from
MSCs to diﬀerentiating phenotype (Figure 6C).
SUMMARY AND CONCLUSIONS
This report provides evidence that the MSC adhesion
“footprint” permits control of MSC growth and targeted
diﬀerentiation. Using enzyme cleavable surfaces, it is shown
that increasing adhesion causes lineage commitment. This
report addresses a major research focus of MSC biologyhow
do they regulate multipotency. MSCs are shown to walk an
extremely ﬁne line between controlled growth with multi-
potency and spontaneous ﬁbroblast diﬀerentiation. We propose
from our data that a small reduction in adhesion by controlling
the integrin subunit use prevents metabolome activation with
associated energy demand required for diﬀerentiation; a larger
reduction in adhesion and tension would result in adipo-
genesis.11,17 On the same surface, we demonstrate that a switch
from FN to VN receptor facilitates both adhesion and BMP
signaling to switch from stem cell growth to osteogenic
commitment through increased levels of intracellular tension.
We note that our analysis relies largely on binning adhesion
length and that analysis in X, Y, and Z may yield further
information.47,48 However, we show that length gives an
eﬀective, easy to use, diﬀerentiation between MSC states of self-
renewal and osteogenesis. Further, we postulate, from ezrin
observations, that potential cytoskeleton decoupling from the
membrane during changes in adhesion dynamics can accelerate
the commitment to diﬀerentiation.
We illustrate that we can reﬁne our protocols by switching
from FMOC to PEG to create a surface that is both amenable
to longer-term dynamic culture and is made from all
biocompatible building blocks. This, and the ability to control
degree of cleavage by switching peptide sequence (Supple-
mentary Figure 6), is a clear advantage of our surfaces.
We present a dynamic surface that clearly shows that the
adhesion/tension balance relationship between a ﬁbroblast (the
“lab weed”) and MSCs (a stem cell with major regenerative
potential) is small. It is thus exciting that materials can be
designed to enhance MSC growth and to study lineage
commitment in a dynamic manner.
MATERIALS AND METHODS
Unless otherwise stated, reagents are from Sigma, UK. Raw data can be
found at doi.org/10.5525/gla.researchdata.324.
Surface Modiﬁcation. Substrates were synthesized as previously
described40 using FMOC protected L-amino acids. Glass coverslips
were sonicated in acetone, ethanol, methanol, and then deionized
water (20 min each). Afterward, coverslips were cleaned for 1 h using a
3:7 piranha solution of 30% hydrogen peroxide and concentrated
Figure 6. Analysis of MSC adhesion and diﬀerentiation on PEG
blocked surfaces. (A) Immunoﬂuorescence images of vinculin in
adhesions at day 5 and STRO-1 at day 21 of culture. On the PEG-
RGD (low) substrates, MSCs were observed to have smaller
adhesions and increased expression of the STRO-1 MSC marker
(arrows) compared to MSCs seeded on RGD cleaved surfaces
(high) where, again, larger adhesions and loss of STRO-1
expression was observed. Red = actin, green = vinculin or STRO-
1, and blue = nucleus. (B) Image analysis after 21 days of culture
conﬁrmed these results, demonstrating that more MSCs retained
STRO-1 expression on PEG-RGD than cells on plain controls and
cleaved RGD surfaces which typically lose STRO-1 much faster
(results are mean ± SD, statistics by ANOVA, *P < 0.05). (C)
Principle component analysis from metabolomics data illustrates
most data homogeneity on PEG-RGD surfaces and most
heterogeneity on the cleaved RGD surface as with the FMOC
blocked samples (n = 3).
ACS Nano Article
DOI: 10.1021/acsnano.6b01765
ACS Nano 2016, 10, 6667−6679
6674
sulfuric acid to remove organic contaminants and then individually
washed in copious amounts of deionized water, dried under nitrogen,
and left at 75 °C overnight. Once dry, surfaces were functionalized
with amine groups as per Piehler et al.,49 to facilitate direct attachment
of amino acids during SPPS. To achieve this, surfaces were silanized
using (3-glycidyloxypropyl)trimethoxysilane at 37 °C for 1 h and
washed with acetone and dried under nitrogen. A diamine-function-
alized polyethylene glycol powder (O,O′-bis(2-aminoethyl)-
octadecaethylene glycol, PEG; CAS no. 892154-56-2) was melted
onto the surfaces at 75 °C for 48 h to attach the PEG linker through
reaction of the epoxy groups on the surface, with the amine groups on
the PEG. Surfaces were cleaned in deionized water to wash oﬀ the
unbound PEG and then dried under nitrogen.
To build up the peptide chain using SPPS, a three-step procedure
was applied. In step 1, the ﬁrst FMOC-protected amino acid (0.2
mmol) was coupled to the PEG monolayer in a solution of
ethyl(hydroxyimino)cyanoacetate (0.4 mmol) and N,N′-diisopropyl-
carbodiimide (0.4 mmol) per 10 mL of anhydrous N,N-dimethylfor-
mamide (DMF). Samples were submerged in solution for 2 h and
gently agitated on an orbital shaker to allow continued mixing of
reagents and removal of byproducts from the sample surface. After this
time, samples were rinsed in DMF, ethanol, methanol, and DMF (5
min each using agitation). A fresh reaction solution containing the
same amino acid was prepared and added to samples, which were then
left overnight under the same conditions described above. Washing
stages using DMF, ethanol, methanol, and DMF were previously
outlined.
For the second step, FMOC groups were removed (deprotected)
using piperidine (20% in DMF) for 2 h under agitation, followed by
washing steps. Subsequent additions of FMOC-protected amino acids
were carried out repeating steps 1 and 2 until the desired peptide
sequence was obtained. The terminating FMOC groups were left in
place. The ﬁnal step (step 3) was to remove side-chain protecting
groups on aspartic acid and glutamic acid residues (O-tert-butyl; OtBu)
and arginine (pentamethyldihydrobenzofuran-5-sulfonyl; Pbf) with a
90% solution of aqueous triﬂuoroacetic acid for 4 h. Samples were
washed and dried and then stored under vacuum in a desiccator or
used straight away. For surfaces terminating in a PEG blocking group
(i.e., PEG-AARGD−), the peptide chain was built up as per the
method for FMOC surfaces with an additional step to remove the
terminating FMOC with piperidine. PEG (O-methyl-O′-succinyl
polyethylene glycol 2000, CAS no. 31961-02-1) was then added to
the terminal amino acid prior to the side-chain protecting groups being
removed.
FMOC and PEG blocking groups were removed in situ by
enzymatic cleavage using porcine pancreatic elastase (Worthington
Biochemical), which was reconstituted in basic culture media and
ﬁltered through 0.22 μm. Throughout this work, the same bottle was
used and certiﬁed as having an enzymatic activity of 4.61 units/mg,
where 1 unit (U) converts 1 μmol of N-succinyltrialynyl-p-nitroanilide
per minute at 25 °C.
Stepwise Monitoring of Solid-Phase Peptide Synthesis.
Water Contact Angle. Water contact angle was carried out using
the sessile drop technique with a KSV CAM 100 contact angle
goniometer (KSV Instruments, USA). High contrast images of static
water droplets were recorded, and CAM 100 software was used to
apply a circular ﬁt to the droplet outline to determine contact angles
across a series of measurements. A total of three droplets were
recorded per surface (25 frames per droplet) and three of each surface
used. Averages were pooled for the main data.
Solid-State Fluorescence Spectroscopy. After each coupling and
deprotection stage, samples were taken from the bulk batch after the
methanol washing stage and rinsed in distilled water, followed by
drying under nitrogen. Samples were analyzed using ﬂuorescence
spectroscopy to conﬁrm the attachment of the FMOC-protected
amino acids and removal of the FMOC group during coupling and
deprotection stages. This technique is as described in literature by
Zelzer et al.,50 taking advantage of the ﬂuorescent properties of the
FMOC group. Fluorescence spectra were measured at room
temperature using a JASCO FP-6500 spectrophotometer (JASCO,
JPN) with spectra manager software. Samples were attached to a glass
microscope slide inserted into a custom-made rotatable holder within
the spectrophotometer chamber. Samples were orientated at 30° to
the incident light to limit the amount of reﬂected excitation light
hitting the detector. Excitation of the surface-tethered FMOC groups
was carried out using an excitation wavelength of 270 nm with a slit
width of 20 nm. Three spectra were recorded at each stage of synthesis
using three diﬀerent samples.
Cell Culture. STRO-1 Selected MSCs. Skeletal STRO-1+ MSCs
were derived from bone marrow obtained from hematologically
normal patients undergoing routine total hip replacement surgery with
the approval of Southampton General Hospital Ethics Committee;
only tissue that is normally discarded was used. Cells were aspirated
from trabecular bone marrow samples and centrifuged at 250g for 4
min at 4 °C. The cell pellet was resuspended in α-MEM and passed
through a 70 μm pore nylon mesh (BD Biosciences). Red blood cells
were removed by centrifugation with lymphoprep gradient solution
(Robbins Scientiﬁc) and the remaining cells in the buﬀy layer
resuspended in 10 mL of blocking solution (4-(2-hydroxyethyl)-1-
piperazine ethanesulfonic acid, HEPES) saline solution with 5% v/v
fetal calf serum, 5% v/v human serum, and 1% w/v bovine serum
albumin (BSA). Afterward, the cells were incubated with a STRO-1
antibody in hybridoma supernatant (hybridoma courtesy of Dr.
Beresford, University of Bath) and ﬂushed with magnetic cell
separation buﬀer (Miltenyi Biotec) to remove any excess antibody.
The cells were incubated with human anti-IgM magnetic microbeads
(Miltenyi Biotec, UK) and added to a magnetic column; the eluent
was collected as the STRO-1− fraction. After being washed with MACs
buﬀer without the magnetic ﬁeld, the eluted cell population was
collected as the STRO-1+ fraction. Skeletal MSCs purchased from
Promocell were used for metabolomics experiments.
MSC Maintenance and Experiment Preparation. MSCs were
maintained at 37 °C and 5% CO2 in α-MEM (PAA Laboratories)
supplemented with 10% v/v fetal bovine serum (FBS) and 2% v/v
antibiotic mix (60% v/v L-glutamine, 35% v/v penicillin−streptomysin,
and 5% v/v ampotericin B). For all experiments, cells were rinsed in
HEPES saline solution (150 mM NaCl, 5 mM KCl, 5 mM glucose, 10
mM HEPES, and 0.5% v/v phenol red indicator adjusted to pH 7.5),
followed by 4 mL of trypsin−versene solution (0.5% v/v trypsin and
versene: 150 mM NaCl, 5 mM KCl, 5 mM glucose, 10 mM HEPES, 1
mM ethylenediaminetetraacetic acid, and 0.5% v/v phenol red
indicator adjusted to pH 7.5) until cells were detached from the
tissue culture ﬂask. Detached cells were transferred to a sterile falcon
tube and centrifuged at 376g for 4 min. The supernatant was discarded
and the cell pellet resuspended in 5 mL of fresh α-MEMs. Cell
numbers were counted using a Neubaur hemocytometer and seeded as
per experimental setup. Prior to use, substrates were sterilized with
70% ethanol (3 × 5 min) and then washed with HEPES saline solution
and basal α-MEM.
Coomassie Blue Staining. To assess cell adhesion, MSCs were
ﬁxed 10% v/v formaldehyde/PBS for 15 min at 37 °C and then stained
with coomassie blue protein dye (0.5% w/v coomassie brilliant blue R-
250 dissolved in 4:1 methanol/acetic acid and ﬁltered with Whatman
ﬁlter paper) for 15 min at room temperature. Excess stain was
removed by washing samples with water until areas around the cells
were clear. Images were taken using a Zeiss Axiovert inverted light
microscope at 10× magniﬁcation (0.25 NA) with a Qimaging digital
CCD camera (Qimaging, Canada) and Qcapture software; n = 3.
Elastase Tolerance. For elastase tolerance, MSCs were seeded onto
plain glass coverslips and left to adhere for 48 h. Porcine pancreatic
elastase was dissolved in α-MEMs at 37 °C as a stock solution and
then ﬁlter sterilized through a 0.22 μm syringe ﬁlter. The stock
solution was diluted across a concentration range of 1.0−0.1 mg/mL
(4.61−0.461 units) and added to samples in place of α-MEMs
(controls were maintained in basic α-MEMs). MSCs were incubated
for a further 24 h and examined for detachment using a Zeiss Axiovert
inverted light microscope at 10× magniﬁcation (0.25 NA) with a
Qimaging digital CCD camera (Qimaging, Canada) and Qcapture
software; n = 3.
ACS Nano Article
DOI: 10.1021/acsnano.6b01765
ACS Nano 2016, 10, 6667−6679
6675
Live/Dead Staining. For live/dead staining during elastase
tolerance, cells were seeded onto plain glass coverslips as described
in Elastase Tolerance section and cultured for 24 h in α-MEM,
followed by a further 24 h of culture in medium containing the titrated
concentrations of elastase (4.61−0.461 units and controls). Additional
“dead” control cells were cultured in the absence of elastase, and 70%
ethanol was added to kill the cells prior to staining. Culture medium
was removed, and cells were washed twice in warm phosphate-buﬀered
saline (PBS), which was then replaced with live/dead assay reagents (2
μM calcein AM and 4 μM ethidium homodimer-1 in PBS) and
incubated at room temperature until color development occurred
(approximately 15 min in the dark). The stain was removed, and the
cells were rinsed twice in warm PBS and imaged using a Zeiss Axiovert
ﬂuorescence microscope.
For live/dead staining of cells cultured on the panel of surfaces, cells
were cultured on plain controls, PEG18, RGD, and RGE controls,
FMOC-RGD, and FMOC-RGE (see Supplementary Figure 2 for
corresponding peptide sequences) for 24 h in α-MEM. Dead control
cells were prepared by adding 70% ethanol to cells cultured on plain
coverslips after 24 h. The cells were stained and imaged as described
above.
Proliferation Assay. Cells were cultured on plain glass coverslips,
plain controls, PEG18, RGD, and RGE controls, FMOC-RGD, and
FMOC-RGE substrates in α-MEM and pulse-labeled with 10 μM 5-
bromo-2-deoxyuridine (BrdU) for 4 h prior to ﬁxation for 1 day and 4
day time points. BrdU-positive MSCs were visualized as described in
Immunocytochemistry.
Phenotype Characterization Pre- and Post-trigger. Cells were
seeded onto plain glass coverslips, RGD controls, and FMOC-RGD
surfaces and cultured in standard α-MEM (see MSC Maintenance and
Experiment Preparation for culture media composition). To cleave the
FMOC blocking group, the culture medium was replaced with
medium containing 0.1 mg/mL elastase for 2 days and then replaced
with standard α-MEM for the remaining length of the culture. The
cells were cultured for a total of 2 weeks.
Induction Medium Experiment. Cells were cultured for 2 weeks on
plain controls and FMOC-RGD surfaces in standard α-MEM. After
this time, samples were divided into three groups: control groups
cultured in standard α-MEM, osteogenic cultures incubated with
osteogenic induction media (350 μM ascorbate-2-phosphate, 0.1 μM
dexamethasone in DMEM with 10% FBS), and adipogenic cultures
that were alternated between adipogenic induction media (1 μM
dexamethasone, 1.7 nM insulin, 200 μM indomethacin, 500 μM
isobutylmethylxanthine in DMEM with 10% FBS, L-glutamine and
antibiotics) and maintenance medium (1.7 nM insulin in DMEM with
10% FBS, 200 mM L-glutamine and antibiotics). The three groups
were cultured for 4 weeks before ﬁxation; n = 3 replicates of each
surface per group.
Cell Population Marker Analysis. Cells were seeded onto plain
controls, RGD controls, and FMOC-RGD substrates. Half of the
FMOC-RGD surfaces were cleaved by replacing the culture medium
with medium containing 0.1 mg/mL elastase after 2 days of culture.
Cells were ﬁxed after 24 h, 3 days, and 5 days of culture as per the
method described in Immunocytochemistry.
Immunocytochemistry. Samples were washed with PBS and ﬁxed
with 10% v/v formaldehyde/PBS for 15 min at 37 °C. Cells were
permeabilized at 4 °C for 5 min (30 mM sucrose, 50 mM NaCl, 3 mM
MgCl2·6H2O, 20 mM HEPES, and 0.5% v/v Triton X-100 in PBS
adjusted to pH 7.2), and nonspeciﬁc binding epitopes were blocked
with 1% w/v BSA/PBS for 15 min at 37 °C (this step was omitted for
anti-BrdU staining). Primary antibodies were made up in PBS/BSA
with rhodamine−phalloidin (1:500; Molecular Probes) with either
1. Mouse monoclonal antivinculin IgG (1:150; Sigma) for
adhesion analysis.
2. Mouse monoclonal anti-phosphomyosin IgG (1:200; Cell
Signaling Technology) for phosphomyosin studies.
3. Mouse monoclonal anti-STRO-1/OPN/OCN IgG (1:50;
Insight Biotechnology) or rabbit polyclonal anti-ALCAM IgG
(1:50; Epitomics) for phenotype analysis and cell population
marker analysis.
4. Mouse monoclonal anti-BrdU (clone BU-1, 1:100 in nuclease
solution, prepared according to the manufacturer’s instructions
in kit RPN202; GE Healthcare) for proliferation studies.
Rhodamine−phalloidin was added with the secondary rather
than the primary antibody.
5. Rabbit polyclonal anti-fatty acid binding protein (FABP; 1:50;
Abcam) or rabbit polyclonal anti-collagen II (COL2A, 1:50;
Insight Bio) for cell phenotype pre- and post-trigger.
Rhodamine−phalloidin was added with the secondary antibody
for collagen II.
6. Rabbit polyclonal anti-RUNX2 (1:50; Insight Bio) or mouse
monoclonal anti-vimentin (1:50; Sigma) for elastase exper-
iments.
7. Rabbit polyclonal anti-ezrin/radixin/moesin (Cell Signaling
Technology; 1:50) for ezrin expression.
Samples were incubated for 1 h (1.5 h for anti-BrdU) at 37 °C, after
which time they were washed in 0.5% v/v Tween 20/PBS (PBST, 3 ×
5 min under gentle agitation) to minimize background labeling. Horse
biotinylated anti-mouse IgG (1:50; Vector Laboratories) or horse
biotinylated anti-rabbit IgG (Vector Laboratories) BSA/PBS was
added to samples and incubated for 1 h at 37 °C. After the washing
stages, samples were incubated for 30 min at 4 °C with ﬂuorescein
isothiocyanate streptavidin (FITC; 1:50; Vector Laboratories) in BSA/
PBS followed by a ﬁnal washing stage. Coverslips were placed on glass
slides in 4′6-diamidino-2-phenylindole mountant (Vector Laborato-
ries).
Cells imaged for adhesions analysis were visualized using a Zeiss
Axiophot ﬂuorescence microscope at 20× magniﬁcation (0.40 NA).
Images were captured using an Evolution QEi digital monochromatic
CCD camera (Media Cybernetics, USA) with Qcapture imaging
software. Cells imaged for phosphomyosin and phenotype analysis
were imaged with a Zeiss Axiovert ﬂuorescence microscope at 20×
magniﬁcation (0.50 NA) and studies at 40× (0.40 NA). Axiovert
images were taken using an Evolution QEi digital monochromatic
CCD camera (Media Cybernetics, USA) with ImagePro software.
Double Immunostaining for Colocalization Studies. Cells seeded
on FMOC-RGD substrates were cultured for 2 days. After this time,
control cells were cultured in standard culture media while test
samples were incubated with 0.1 mg/mL elastase for 24 and 48 h.
Colocalization of BMPR1A with the integrins β1 and β5 was
performed using immunocytochemistry in the previous section. After
ﬁxation, samples were incubated with a primary antibody cocktail
consisting of rabbit polyclonal anti-BMPR1A (Thermo Scientiﬁc;
1:50), mouse monoclonal anti-integrin β1 (Thermo Scientiﬁc; 1:50),
and mouse anti-integrin αvβ5 (R&D system, 1:50) in 1% of BSA/PBS.
Secondary antibodies were Texas red anti-mouse (Vector Laborato-
ries; 1:50) for integrin β1 and β5 and biotinylated anti-rabbit (Vector
laboratories) conjugated with FITC for BMPR1A.
Cells imaged for colocalization of BMPR1A with integrin β1 and β5
were visualized using a Zeiss Axiophot ﬂuorescence microscope at 40×
magniﬁcation (0.75 NA). Images were captured using an Evolution
QEi digital monochromatic CCD camera (Media Cybernetics, USA)
with Qcapture imaging software.
RNA Interference. RNA interference was performed using non-
targeting siRNA (cat no. D001810-01-05) and human ezrin−siRNA
(cat no. L-017370-00) purchased from GE Healthcare. Transfections
were carried out using DharmaFECT Transfection Reagents (GE
Healthcare) according to the manufacturer’s instructions.
In Cell Western. Cells on substrates were washed with PBS and
ﬁxed with 10% v/v formaldehyde/PBS for 15 min at 37 °C. Cells were
permeabilized using precooled methanol at 4 °C for 10 min, and
nonspeciﬁc binding epitopes were blocked with 1% milk protein in
0.1% Tween 20/PBS (PBST) for 1 h at room temperature. Cells were
then washed three times (3 × 5 min) with 0.1% PBST. Primary
antibodies diluted in 1% milk/PBST containing cell tag 700CW stain
(1:500; LI-COR, cat no. 926-41090) with either
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1. Rabbit polyclonal anti-ezrin/radixin/moesin (Cell Signaling
Technology; 1:50) for ezrin knock-down eﬃciency measur-
ement.
2. Rabbit polyclonal RUNX2 (Santa Cruz; 1:50) expression in
ezrin knock-down cells.
3. Rabbit polyclonal phospho-RUNX2 pSer465 (Thermo Scien-
tiﬁc; 1:50) for phospho-UNX2 expression in ezrin knock-down
cells.
Cells with primary antibodies were incubated at room temperature
for 1 h and then washed with 0.1% PBST three times. After being
washed, cells with secondary antibodyeither IRDye 800CW, goat
anti-mouse (LI-COR, cat no. 926-32210), or donkey anti-rabbit (LI-
COR, cat no. 926-32213) diluted in 1% milk/PBST at 1:1000 were
incubated at room temperature for 1 h or at 4 °C for overnight. After
the washing stage, cells were subjected to a LI-COR Odyssey Sa
(0157) scanner. The protein of interest was scanned at channel 800
and CellTag at channel 700 (scan parameters: focus oﬀset = 2.0 mm,
scan resolution = 100 μm, intensity = 12). Data were collected in
integrated intensity (IntegInten) and analyzed by one-way analysis of
variance (ANOVA) and Dunn’s post-hoc test applied where
signiﬁcance was determined as P < 0.05.
Image Analysis. Fluorescence microscopy images were exported to
Adobe Photoshop for the purpose of labeling and superimposing color
channels. For size analysis, actin images were exported to ImageJ
(http://rsbweb.nih.gov/ij/download.html) to calculate cell area using
the threshold tool. For adhesion analysis, vinculin images were
exported to Adobe Photoshop, and each individual adhesion was
traced with a 1 pixel width line to create an adhesion mask
superimposed over the background image. ImageJ was then used to
determine total adhesion numbers and length; individual subtypes
were plotted as a percentage of the overall number of adhesions
recorded. For the proliferation analysis, the percentage of BrdU-
positive cells was quantiﬁed for at least 150 cells per sample type and
normalized to determine the percentage change relative to the glass
controls. Analysis of the maintenance of STRO-1+ expression of
staining over time was performed by allocating cells into categories (at
least 50 cells per surface type), indicating the features of the staining.
In order to determine phosphomyosin expression, or STRO-1+
expression for cell population analysis (at least 50 cells per sample
type), grayscale images were exported into ImageJ and individual cells
were selected with the polygon tool. Using the method described in
Burgess et al.,51,52 phosphomyosin expression was calculated using
integrated density (ID) values where ID = (area × mean gray value).
Calculations were then corrected for background ﬂuorescence using
the formula ID − (cell area × ID of background ﬂuorescence). In
order to quantify the expression of phenotypic markers, ﬂuorescence
images were exported to ImageJ and highlighted with the threshold
tool. Integrated density values (area × mean gray value) were
recorded, and these values were divided by the number of nuclei to
average ﬂuorescence across the number of cells in the same ﬁeld of
view. As the background ﬂuorescence could not be recorded because
of cell conﬂuency, only images taken at similar exposure levels were
used.
Data were analyzed by ANOVA and Dunn’s post-hoc test applied or
t-tests to identify any signiﬁcant diﬀerences between the groups, where
signiﬁcance was determined as P < 0.5.
MTT Assay. After 5 days, 100 μL of 5 mg/mL MTT
(methylthiazolyldiphenyl tetrazolium bromide) solution in complete
cell culture media was added to the cells for 2 h. After this time, the
medium was removed and replaced with DMSO for 5 min. Liquid
from each well was then analyzed at 570 nm (background set to 670
nm) and optical density reported.
Metabolomics. For metabolomic analysis, substrates were removed
from the well plates and transferred to new sterile plates so that only
cells that were attached to the substrates were used in the analysis.
Substrates were washed once with warmed PBS, and then 0.5 mL of
ice-cold extraction solvent (chloroform/methanol/water at 1:3:1 v/v)
was added to the wells. Plates were sealed with paraﬁlm to minimize
evaporation and placed on a rotary shaker for 1 h at 4 °C. After this
time, the extraction solvent was transferred to sterile 0.5 mL
Eppendorf tubes and centrifuged at 13 000g for 5 min to remove
cell debris. The supernatant was transferred to LC vials; otherwise,
samples were stored at −80 °C in Eppendorf tubes until use. For
elastase studies, all samples were processed in-well with 150 μL of
extraction solvent added to each well. Samples were then processed as
above.
All samples were diluted 1 in 2 with acetonitrile prior to being
aspirated to HPLC vials; an additional 5 μL of each sample was
combined into a single aliquot to be used as a quality control sample.
This pooled sample was injected several times throughout the duration
of each run in order to monitor metabolite quality and sample
degradation. Three standards containing a number of known
metabolites were also run alongside unknown samples for the purpose
of identifying all other metabolites. Chromatographic separation of
metabolites was performed using an UltiMate 3000 RS-LC (Thermo
Fisher) with a zwitterionic hydrophilic interaction liquid chromatog-
raphy (ZIC-HILIC) column (C18 150 × 4.6 mm; Merck Sequant) as
the stationary phase, 1% v/v formic acid in acetonitrile as the organic
mobile phase, and 1% v/v aqueous formic acid as the aqueous mobile
phase. The mobile phase was run as a gradient over 46 min (Table 1).
Injection volumes were 10 μL, and a ZIC-HILIC C8 20 × 2.0 guard
column was used to protect the main column from impurities;
chromatography columns were maintained at 25 °C.
MS was performed using an Orbitrap Exactive accurate mass mass
spectrometer (Thermo Fisher Scientiﬁc). Scans were conducted at a
mass resolution of 50 000 in both positive and negative ion modes
across a range of 70−1400 m/z. Prior to data acquisition, mass
calibration was performed in positive and negative modes using a
calibration mix containing a number of compounds with known
masses across the acquisition range. Data conversion, chromatographic
peak selection, and metabolite identiﬁcation were carried out using the
IDEOM/MzMatch Excel interface,53,54 and chromatographic peak
intensities (peak area under the curve) were normalized against
calculated protein content. Known standards were used to deﬁne both
mass and retention times of analytes. Putative metabolites were also
identiﬁed on this basis using predicted retention times as described in
Creek et al.55 MetaboAnalyst56 and Ingenuity pathway analysis were
used to generate illustrations.
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS).
ToF-SIMS analysis was carried out with a ToF-SIMS IV time-of-ﬂight
instrument (ION-ToF GmbH). Secondary ions were generated using
a primary ion beam from a 25 kV Bi3
+ liquid metal ion source with a 1
pA pulsed target current. The primary ion dose was kept below the
static limit (less than 2.45 × 1012 ions/cm2). Built-up surface charge
was compensated using an electron gun, producing a ﬂux of low-
energy electrons (20 eV). Secondary ions were subjected to a post-
acceleration voltage of 10 kV and analyzed with positive polarity with a
single stage reﬂectron analyzer. Images were acquired by rastering the
primary ion beam across the sample surface. On each sample, two
small scale (500 μm × 500 μm; 2 μm resolution) and one large scale
(3 mm × 3 mm; 10 μm resolution) areas were imaged.
Table 1. LC−MS Mobile Phase Parametersa
time
(min)
aqueous
(%)
organic
(%)
ﬂow rate
(mL/min)
gradient
curve
0 20 80 0.3 1
30 20 80 0.3 6
32 80 20 0.3 6
40 95 5 0.3 6
42 95 5 0.3 6
aChromatographic separation of metabolites was carried out using an
organic (1% v/v formic acid in acetonitrile)/aqueous (1% v/v aqueous
formic acid) mobile phase run over a period of 46 min. Table data
show the percentage of each mobile phase at particular time points,
ﬂow rate, and gradient curve conditions.
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The data were processed using Surface Lab 6. Mass spectra were
calibrated to known reference peaks from H+, CH3
+, C2H5
+, C3H7
+,
and C4H9
+. Peaks from the samples were assigned to PEG, FMOC,
and the amino acids according to reference data from the
literature.40,57,58 Ion intensity images were generated from these ions
of interest by the software.
For qualitative assessment of sample uniformity and presence of
chemical functionalities, small-scale images (500 μm × 500 μm) were
used and the ions associated with amino acids were summed up and
combined in a single image. The ion count scale for speciﬁc ion images
(PEG, FMOC, amino acids) was manually adjusted to the same range
for each sample to allow direct comparison. Total ion images were
scaled individually.
For semiquantitative assessment of the relative amount of FMOC
removed from the surface, the large-scale images (3 mm × 3 mm; one
per sample type) were normalized to the total ion counts and divided
into four regions of interest (ROI) that correspond to four equally
sized, non-overlapping quadrants (1.5 mm × 1.5 mm) of the image.
Normalized ion intensities for an FMOC-related ion (C14H11
+, m/z =
179) were generated for each ROI by the software to provide four data
sets for each sample that were used to calculate a mean and standard
deviation for the FMOC ion intensities before and after exposure of
FMOC-AARGD and FMOC-FARGD to elastase. These normalized
intensities were used to calculate a percentage decrease of FMOC on
the two sample types. It should be noted that this method to generate
numeric data of surface densities of chemical compounds is sensitive to
small amounts of material on the surface but not fully quantitative due
to a variety of factors aﬀecting measured ion intensities from ToF-
SIMS.
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